These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4995735)

  • 21. [Mechanism of the immunological adjuvant effect of vaccinia-virus].
    Bandlow G; Fischer W; Thomssen R
    Arch Gesamte Virusforsch; 1972; 38(2):192-204. PubMed ID: 4198012
    [No Abstract]   [Full Text] [Related]  

  • 22. Some observations on the behavior of vaccinia virus particles with antiserum, particularly their agglutination.
    Galasso GJ; Sharp DG
    J Immunol; 1965 Oct; 95(4):737-42. PubMed ID: 5841056
    [No Abstract]   [Full Text] [Related]  

  • 23. Neutralizing activities of antisera to poxvirus soluble antigens.
    Appleyard G; Andrews C
    J Gen Virol; 1974 May; 23(2):197-200. PubMed ID: 4833605
    [No Abstract]   [Full Text] [Related]  

  • 24. COMPARATIVE STUDIES OF PIGPOX AND VACCINIA VIRUSES. II. SEROLOGICAL RELATIONSHIP.
    DATT NS
    J Comp Pathol; 1964 Jan; 74():70-80. PubMed ID: 14105242
    [No Abstract]   [Full Text] [Related]  

  • 25. Experiences with improvement of the neutralization reaction with vaccinia virus in chick fibroblast cultures.
    Aksenov OA; Smorodintsev AA
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(4):488-98. PubMed ID: 6006816
    [No Abstract]   [Full Text] [Related]  

  • 26. The neutralization of pox viruses. II. Relationships between vaccinia, rabbitpox, cowpox and ectromelia.
    McNeill TA
    J Hyg (Lond); 1968 Dec; 66(4):549-55. PubMed ID: 5250179
    [No Abstract]   [Full Text] [Related]  

  • 27. Serological relationships between poxviruses of different genera: studies with vaccinia virus and myxoma virus.
    Alcock SR
    J Comp Pathol; 1981 Oct; 91(4):493-502. PubMed ID: 6172453
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunofluorescence test for persistent poxvirus antibodies.
    Gispen R; Huisman J; Brand-Saathof B; Hekker AC
    Arch Gesamte Virusforsch; 1974; 44(4):391-5. PubMed ID: 4212070
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
    Leddy JP; Simons RL; Douglas RG
    J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abortive replication of CV1 strain of vaccinia virus in human embryo kidney cells.
    Dunlap RC; Meyer HM
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):779-84. PubMed ID: 4587882
    [No Abstract]   [Full Text] [Related]  

  • 31. Titration of relative neutralizing potency of vaccinia immune serum in tube cultures of monkey kidney cells.
    MIDDELHOVEN WJ
    Arch Gesamte Virusforsch; 1962; 11():644-57. PubMed ID: 14473539
    [No Abstract]   [Full Text] [Related]  

  • 32. The neutralization of pox viruses. I. Evidence for antibody interference.
    M Neill TA
    J Hyg (Lond); 1968 Dec; 66(4):541-8. PubMed ID: 5250178
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of oxidized spermine and other aldehydes on the infectivity of vaccinia virus.
    Bachrach U; Rosenkovitch E
    Appl Microbiol; 1972 Feb; 23(2):232-5. PubMed ID: 4622820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a novel vaccinia-neutralization assay based on reporter-gene expression.
    Manischewitz J; King LR; Bleckwenn NA; Shiloach J; Taffs R; Merchlinsky M; Eller N; Mikolajczyk MG; Clanton DJ; Monath T; Weltzin RA; Scott DE; Golding H
    J Infect Dis; 2003 Aug; 188(3):440-8. PubMed ID: 12870127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of rheumatoid factor with infectious vaccinia virus-antibody complexes.
    Gipson TG; Daniels CA; Notkins AL
    J Immunol; 1974 Jun; 112(6):2087-93. PubMed ID: 4207730
    [No Abstract]   [Full Text] [Related]  

  • 36. Yellow fever virus. I. Development and evaluation of a plaque neutralization test.
    Spector S; Tauraso NM
    Appl Microbiol; 1968 Nov; 16(11):1770-5. PubMed ID: 4973067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens.
    Ueda Y; Tagaya I
    J Exp Med; 1973 Nov; 138(5):1033-43. PubMed ID: 4744920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SEROLOGIC STUDIES OF AFRICAN HORSE-SICKNESS VIRUS WITH EMPHASIS ON NEUTRALIZATION TEST IN TISSUE CULTURE.
    HAZRATI A; OZAWA Y
    Can J Comp Med Vet Sci; 1965 Jul; 29(7):173-8. PubMed ID: 14300857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus serum neutralization in micro-tissue cultures of rhesus monkey kidney cells.
    Furesz J; Armstrong RE; Nagler FP
    Can J Microbiol; 1972 Oct; 18(10):1603-6. PubMed ID: 4628184
    [No Abstract]   [Full Text] [Related]  

  • 40. Yellow fever virus. II. Factors affecting the plaque neutralization test.
    Spector SL; Tauraso NM
    Appl Microbiol; 1969 Nov; 18(5):736-43. PubMed ID: 4984200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.